Global Estrogen and Progestin Extended-Release Patches Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Estrogen and Progestin Extended-Release Patches market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Estrogen and Progestin Extended-Release Patches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Estrogen and Progestin Extended-Release Patches market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Estrogen and Progestin Extended-Release Patches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Estrogen and Progestin Extended-Release Patches market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Estrogen and Progestin Extended-Release Patches market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Estrogen and Progestin Extended-Release Patches
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Estrogen and Progestin Extended-Release Patches market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals and Noven, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Estrogen and Progestin Extended-Release Patches market is split by Type and by Sales Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Estrogen and Progestin Extended-Release Patches product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Estrogen and Progestin Extended-Release Patches, with price, sales, revenue and global market share of Estrogen and Progestin Extended-Release Patches from 2018 to 2023.
Chapter 3, the Estrogen and Progestin Extended-Release Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Estrogen and Progestin Extended-Release Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and sales channel, with sales market share and growth rate by type, sales channel, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Estrogen and Progestin Extended-Release Patches market forecast, by regions, type and sales channel, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Estrogen and Progestin Extended-Release Patches.
Chapter 14 and 15, to describe Estrogen and Progestin Extended-Release Patches sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Estrogen and Progestin Extended-Release Patches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Estrogen and Progestin Extended-Release Patches market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Estrogen and Progestin Extended-Release Patches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Estrogen and Progestin Extended-Release Patches market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Estrogen and Progestin Extended-Release Patches market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Estrogen and Progestin Extended-Release Patches
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Estrogen and Progestin Extended-Release Patches market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals and Noven, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Estrogen and Progestin Extended-Release Patches market is split by Type and by Sales Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Contraceptive Patch
- Estradiol Patch
- Others
- Online Sales
- Offline Sales
- Mylan Pharmaceuticals Inc.(Viatris)
- Twirla
- Novartis(HEXAL AG)
- Bayer Healthcare Pharmaceuticals
- Noven
- AbbVie
- Hisamitsu Pharmaceutical Co., Inc.
- Watson Pharmaceuticals
- Johnson & Johnson
- ANI Pharmaceuticals
- Zhejiang Yatai Pharmaceutical Company Ltd.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Estrogen and Progestin Extended-Release Patches product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Estrogen and Progestin Extended-Release Patches, with price, sales, revenue and global market share of Estrogen and Progestin Extended-Release Patches from 2018 to 2023.
Chapter 3, the Estrogen and Progestin Extended-Release Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Estrogen and Progestin Extended-Release Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and sales channel, with sales market share and growth rate by type, sales channel, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Estrogen and Progestin Extended-Release Patches market forecast, by regions, type and sales channel, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Estrogen and Progestin Extended-Release Patches.
Chapter 14 and 15, to describe Estrogen and Progestin Extended-Release Patches sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Estrogen and Progestin Extended-Release Patches
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Contraceptive Patch
1.3.3 Estradiol Patch
1.3.4 Others
1.4 Market Analysis by Sales Channel
1.4.1 Overview: Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel: 2018 Versus 2022 Versus 2029
1.4.2 Online Sales
1.4.3 Offline Sales
1.5 Global Estrogen and Progestin Extended-Release Patches Market Size & Forecast
1.5.1 Global Estrogen and Progestin Extended-Release Patches Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Estrogen and Progestin Extended-Release Patches Sales Quantity (2018-2029)
1.5.3 Global Estrogen and Progestin Extended-Release Patches Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Mylan Pharmaceuticals Inc.(Viatris)
2.1.1 Mylan Pharmaceuticals Inc.(Viatris) Details
2.1.2 Mylan Pharmaceuticals Inc.(Viatris) Major Business
2.1.3 Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Product and Services
2.1.4 Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Mylan Pharmaceuticals Inc.(Viatris) Recent Developments/Updates
2.2 Twirla
2.2.1 Twirla Details
2.2.2 Twirla Major Business
2.2.3 Twirla Estrogen and Progestin Extended-Release Patches Product and Services
2.2.4 Twirla Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Twirla Recent Developments/Updates
2.3 Novartis(HEXAL AG)
2.3.1 Novartis(HEXAL AG) Details
2.3.2 Novartis(HEXAL AG) Major Business
2.3.3 Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Product and Services
2.3.4 Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis(HEXAL AG) Recent Developments/Updates
2.4 Bayer Healthcare Pharmaceuticals
2.4.1 Bayer Healthcare Pharmaceuticals Details
2.4.2 Bayer Healthcare Pharmaceuticals Major Business
2.4.3 Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
2.4.4 Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Healthcare Pharmaceuticals Recent Developments/Updates
2.5 Noven
2.5.1 Noven Details
2.5.2 Noven Major Business
2.5.3 Noven Estrogen and Progestin Extended-Release Patches Product and Services
2.5.4 Noven Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Noven Recent Developments/Updates
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Estrogen and Progestin Extended-Release Patches Product and Services
2.6.4 AbbVie Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AbbVie Recent Developments/Updates
2.7 Hisamitsu Pharmaceutical Co., Inc.
2.7.1 Hisamitsu Pharmaceutical Co., Inc. Details
2.7.2 Hisamitsu Pharmaceutical Co., Inc. Major Business
2.7.3 Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Product and Services
2.7.4 Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
2.8 Watson Pharmaceuticals
2.8.1 Watson Pharmaceuticals Details
2.8.2 Watson Pharmaceuticals Major Business
2.8.3 Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
2.8.4 Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Watson Pharmaceuticals Recent Developments/Updates
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Estrogen and Progestin Extended-Release Patches Product and Services
2.9.4 Johnson & Johnson Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Johnson & Johnson Recent Developments/Updates
2.10 ANI Pharmaceuticals
2.10.1 ANI Pharmaceuticals Details
2.10.2 ANI Pharmaceuticals Major Business
2.10.3 ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
2.10.4 ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ANI Pharmaceuticals Recent Developments/Updates
2.11 Zhejiang Yatai Pharmaceutical Company Ltd.
2.11.1 Zhejiang Yatai Pharmaceutical Company Ltd. Details
2.11.2 Zhejiang Yatai Pharmaceutical Company Ltd. Major Business
2.11.3 Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Product and Services
2.11.4 Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zhejiang Yatai Pharmaceutical Company Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ESTROGEN AND PROGESTIN EXTENDED-RELEASE PATCHES BY MANUFACTURER
3.1 Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Manufacturer (2018-2023)
3.2 Global Estrogen and Progestin Extended-Release Patches Revenue by Manufacturer (2018-2023)
3.3 Global Estrogen and Progestin Extended-Release Patches Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Estrogen and Progestin Extended-Release Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Estrogen and Progestin Extended-Release Patches Manufacturer Market Share in 2022
3.4.2 Top 6 Estrogen and Progestin Extended-Release Patches Manufacturer Market Share in 2022
3.5 Estrogen and Progestin Extended-Release Patches Market: Overall Company Footprint Analysis
3.5.1 Estrogen and Progestin Extended-Release Patches Market: Region Footprint
3.5.2 Estrogen and Progestin Extended-Release Patches Market: Company Product Type Footprint
3.5.3 Estrogen and Progestin Extended-Release Patches Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Estrogen and Progestin Extended-Release Patches Market Size by Region
4.1.1 Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2029)
4.1.2 Global Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2029)
4.1.3 Global Estrogen and Progestin Extended-Release Patches Average Price by Region (2018-2029)
4.2 North America Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
4.3 Europe Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
4.4 Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
4.5 South America Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
4.6 Middle East and Africa Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
5.2 Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type (2018-2029)
5.3 Global Estrogen and Progestin Extended-Release Patches Average Price by Type (2018-2029)
6 MARKET SEGMENT BY SALES CHANNEL
6.1 Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
6.2 Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel (2018-2029)
6.3 Global Estrogen and Progestin Extended-Release Patches Average Price by Sales Channel (2018-2029)
7 NORTH AMERICA
7.1 North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
7.2 North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
7.3 North America Estrogen and Progestin Extended-Release Patches Market Size by Country
7.3.1 North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2029)
7.3.2 North America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
8.2 Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
8.3 Europe Estrogen and Progestin Extended-Release Patches Market Size by Country
8.3.1 Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2029)
8.3.2 Europe Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
9.3 Asia-Pacific Estrogen and Progestin Extended-Release Patches Market Size by Region
9.3.1 Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
10.2 South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
10.3 South America Estrogen and Progestin Extended-Release Patches Market Size by Country
10.3.1 South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2029)
10.3.2 South America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
11.3 Middle East & Africa Estrogen and Progestin Extended-Release Patches Market Size by Country
11.3.1 Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Estrogen and Progestin Extended-Release Patches Market Drivers
12.2 Estrogen and Progestin Extended-Release Patches Market Restraints
12.3 Estrogen and Progestin Extended-Release Patches Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Estrogen and Progestin Extended-Release Patches and Key Manufacturers
13.2 Manufacturing Costs Percentage of Estrogen and Progestin Extended-Release Patches
13.3 Estrogen and Progestin Extended-Release Patches Production Process
13.4 Estrogen and Progestin Extended-Release Patches Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Estrogen and Progestin Extended-Release Patches Typical Distributors
14.3 Estrogen and Progestin Extended-Release Patches Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Estrogen and Progestin Extended-Release Patches
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Contraceptive Patch
1.3.3 Estradiol Patch
1.3.4 Others
1.4 Market Analysis by Sales Channel
1.4.1 Overview: Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel: 2018 Versus 2022 Versus 2029
1.4.2 Online Sales
1.4.3 Offline Sales
1.5 Global Estrogen and Progestin Extended-Release Patches Market Size & Forecast
1.5.1 Global Estrogen and Progestin Extended-Release Patches Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Estrogen and Progestin Extended-Release Patches Sales Quantity (2018-2029)
1.5.3 Global Estrogen and Progestin Extended-Release Patches Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Mylan Pharmaceuticals Inc.(Viatris)
2.1.1 Mylan Pharmaceuticals Inc.(Viatris) Details
2.1.2 Mylan Pharmaceuticals Inc.(Viatris) Major Business
2.1.3 Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Product and Services
2.1.4 Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Mylan Pharmaceuticals Inc.(Viatris) Recent Developments/Updates
2.2 Twirla
2.2.1 Twirla Details
2.2.2 Twirla Major Business
2.2.3 Twirla Estrogen and Progestin Extended-Release Patches Product and Services
2.2.4 Twirla Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Twirla Recent Developments/Updates
2.3 Novartis(HEXAL AG)
2.3.1 Novartis(HEXAL AG) Details
2.3.2 Novartis(HEXAL AG) Major Business
2.3.3 Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Product and Services
2.3.4 Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis(HEXAL AG) Recent Developments/Updates
2.4 Bayer Healthcare Pharmaceuticals
2.4.1 Bayer Healthcare Pharmaceuticals Details
2.4.2 Bayer Healthcare Pharmaceuticals Major Business
2.4.3 Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
2.4.4 Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Healthcare Pharmaceuticals Recent Developments/Updates
2.5 Noven
2.5.1 Noven Details
2.5.2 Noven Major Business
2.5.3 Noven Estrogen and Progestin Extended-Release Patches Product and Services
2.5.4 Noven Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Noven Recent Developments/Updates
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Estrogen and Progestin Extended-Release Patches Product and Services
2.6.4 AbbVie Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AbbVie Recent Developments/Updates
2.7 Hisamitsu Pharmaceutical Co., Inc.
2.7.1 Hisamitsu Pharmaceutical Co., Inc. Details
2.7.2 Hisamitsu Pharmaceutical Co., Inc. Major Business
2.7.3 Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Product and Services
2.7.4 Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
2.8 Watson Pharmaceuticals
2.8.1 Watson Pharmaceuticals Details
2.8.2 Watson Pharmaceuticals Major Business
2.8.3 Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
2.8.4 Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Watson Pharmaceuticals Recent Developments/Updates
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Estrogen and Progestin Extended-Release Patches Product and Services
2.9.4 Johnson & Johnson Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Johnson & Johnson Recent Developments/Updates
2.10 ANI Pharmaceuticals
2.10.1 ANI Pharmaceuticals Details
2.10.2 ANI Pharmaceuticals Major Business
2.10.3 ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
2.10.4 ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ANI Pharmaceuticals Recent Developments/Updates
2.11 Zhejiang Yatai Pharmaceutical Company Ltd.
2.11.1 Zhejiang Yatai Pharmaceutical Company Ltd. Details
2.11.2 Zhejiang Yatai Pharmaceutical Company Ltd. Major Business
2.11.3 Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Product and Services
2.11.4 Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zhejiang Yatai Pharmaceutical Company Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ESTROGEN AND PROGESTIN EXTENDED-RELEASE PATCHES BY MANUFACTURER
3.1 Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Manufacturer (2018-2023)
3.2 Global Estrogen and Progestin Extended-Release Patches Revenue by Manufacturer (2018-2023)
3.3 Global Estrogen and Progestin Extended-Release Patches Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Estrogen and Progestin Extended-Release Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Estrogen and Progestin Extended-Release Patches Manufacturer Market Share in 2022
3.4.2 Top 6 Estrogen and Progestin Extended-Release Patches Manufacturer Market Share in 2022
3.5 Estrogen and Progestin Extended-Release Patches Market: Overall Company Footprint Analysis
3.5.1 Estrogen and Progestin Extended-Release Patches Market: Region Footprint
3.5.2 Estrogen and Progestin Extended-Release Patches Market: Company Product Type Footprint
3.5.3 Estrogen and Progestin Extended-Release Patches Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Estrogen and Progestin Extended-Release Patches Market Size by Region
4.1.1 Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2029)
4.1.2 Global Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2029)
4.1.3 Global Estrogen and Progestin Extended-Release Patches Average Price by Region (2018-2029)
4.2 North America Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
4.3 Europe Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
4.4 Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
4.5 South America Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
4.6 Middle East and Africa Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
5.2 Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type (2018-2029)
5.3 Global Estrogen and Progestin Extended-Release Patches Average Price by Type (2018-2029)
6 MARKET SEGMENT BY SALES CHANNEL
6.1 Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
6.2 Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel (2018-2029)
6.3 Global Estrogen and Progestin Extended-Release Patches Average Price by Sales Channel (2018-2029)
7 NORTH AMERICA
7.1 North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
7.2 North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
7.3 North America Estrogen and Progestin Extended-Release Patches Market Size by Country
7.3.1 North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2029)
7.3.2 North America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
8.2 Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
8.3 Europe Estrogen and Progestin Extended-Release Patches Market Size by Country
8.3.1 Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2029)
8.3.2 Europe Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
9.3 Asia-Pacific Estrogen and Progestin Extended-Release Patches Market Size by Region
9.3.1 Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
10.2 South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
10.3 South America Estrogen and Progestin Extended-Release Patches Market Size by Country
10.3.1 South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2029)
10.3.2 South America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2029)
11.3 Middle East & Africa Estrogen and Progestin Extended-Release Patches Market Size by Country
11.3.1 Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Estrogen and Progestin Extended-Release Patches Market Drivers
12.2 Estrogen and Progestin Extended-Release Patches Market Restraints
12.3 Estrogen and Progestin Extended-Release Patches Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Estrogen and Progestin Extended-Release Patches and Key Manufacturers
13.2 Manufacturing Costs Percentage of Estrogen and Progestin Extended-Release Patches
13.3 Estrogen and Progestin Extended-Release Patches Production Process
13.4 Estrogen and Progestin Extended-Release Patches Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Estrogen and Progestin Extended-Release Patches Typical Distributors
14.3 Estrogen and Progestin Extended-Release Patches Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Table 3. Mylan Pharmaceuticals Inc.(Viatris) Basic Information, Manufacturing Base and Competitors
Table 4. Mylan Pharmaceuticals Inc.(Viatris) Major Business
Table 5. Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Product and Services
Table 6. Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Mylan Pharmaceuticals Inc.(Viatris) Recent Developments/Updates
Table 8. Twirla Basic Information, Manufacturing Base and Competitors
Table 9. Twirla Major Business
Table 10. Twirla Estrogen and Progestin Extended-Release Patches Product and Services
Table 11. Twirla Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Twirla Recent Developments/Updates
Table 13. Novartis(HEXAL AG) Basic Information, Manufacturing Base and Competitors
Table 14. Novartis(HEXAL AG) Major Business
Table 15. Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Product and Services
Table 16. Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis(HEXAL AG) Recent Developments/Updates
Table 18. Bayer Healthcare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Healthcare Pharmaceuticals Major Business
Table 20. Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
Table 21. Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Healthcare Pharmaceuticals Recent Developments/Updates
Table 23. Noven Basic Information, Manufacturing Base and Competitors
Table 24. Noven Major Business
Table 25. Noven Estrogen and Progestin Extended-Release Patches Product and Services
Table 26. Noven Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Noven Recent Developments/Updates
Table 28. AbbVie Basic Information, Manufacturing Base and Competitors
Table 29. AbbVie Major Business
Table 30. AbbVie Estrogen and Progestin Extended-Release Patches Product and Services
Table 31. AbbVie Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AbbVie Recent Developments/Updates
Table 33. Hisamitsu Pharmaceutical Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Hisamitsu Pharmaceutical Co., Inc. Major Business
Table 35. Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Product and Services
Table 36. Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
Table 38. Watson Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Watson Pharmaceuticals Major Business
Table 40. Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
Table 41. Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Watson Pharmaceuticals Recent Developments/Updates
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson Estrogen and Progestin Extended-Release Patches Product and Services
Table 46. Johnson & Johnson Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Johnson & Johnson Recent Developments/Updates
Table 48. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. ANI Pharmaceuticals Major Business
Table 50. ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
Table 51. ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. ANI Pharmaceuticals Recent Developments/Updates
Table 53. Zhejiang Yatai Pharmaceutical Company Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Zhejiang Yatai Pharmaceutical Company Ltd. Major Business
Table 55. Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Product and Services
Table 56. Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Zhejiang Yatai Pharmaceutical Company Ltd. Recent Developments/Updates
Table 58. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Estrogen and Progestin Extended-Release Patches Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Estrogen and Progestin Extended-Release Patches Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Estrogen and Progestin Extended-Release Patches, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Estrogen and Progestin Extended-Release Patches Production Site of Key Manufacturer
Table 63. Estrogen and Progestin Extended-Release Patches Market: Company Product Type Footprint
Table 64. Estrogen and Progestin Extended-Release Patches Market: Company Product Application Footprint
Table 65. Estrogen and Progestin Extended-Release Patches New Market Entrants and Barriers to Market Entry
Table 66. Estrogen and Progestin Extended-Release Patches Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Estrogen and Progestin Extended-Release Patches Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Estrogen and Progestin Extended-Release Patches Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Estrogen and Progestin Extended-Release Patches Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Estrogen and Progestin Extended-Release Patches Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 80. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 81. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel (2018-2023) & (USD Million)
Table 82. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel (2024-2029) & (USD Million)
Table 83. Global Estrogen and Progestin Extended-Release Patches Average Price by Sales Channel (2018-2023) & (US$/Unit)
Table 84. Global Estrogen and Progestin Extended-Release Patches Average Price by Sales Channel (2024-2029) & (US$/Unit)
Table 85. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 88. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 89. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 96. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 97. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 104. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 105. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 112. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 113. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 120. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 121. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Estrogen and Progestin Extended-Release Patches Raw Material
Table 126. Key Manufacturers of Estrogen and Progestin Extended-Release Patches Raw Materials
Table 127. Estrogen and Progestin Extended-Release Patches Typical Distributors
Table 128. Estrogen and Progestin Extended-Release Patches Typical Customers
Table 1. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Table 3. Mylan Pharmaceuticals Inc.(Viatris) Basic Information, Manufacturing Base and Competitors
Table 4. Mylan Pharmaceuticals Inc.(Viatris) Major Business
Table 5. Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Product and Services
Table 6. Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Mylan Pharmaceuticals Inc.(Viatris) Recent Developments/Updates
Table 8. Twirla Basic Information, Manufacturing Base and Competitors
Table 9. Twirla Major Business
Table 10. Twirla Estrogen and Progestin Extended-Release Patches Product and Services
Table 11. Twirla Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Twirla Recent Developments/Updates
Table 13. Novartis(HEXAL AG) Basic Information, Manufacturing Base and Competitors
Table 14. Novartis(HEXAL AG) Major Business
Table 15. Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Product and Services
Table 16. Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis(HEXAL AG) Recent Developments/Updates
Table 18. Bayer Healthcare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Healthcare Pharmaceuticals Major Business
Table 20. Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
Table 21. Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Healthcare Pharmaceuticals Recent Developments/Updates
Table 23. Noven Basic Information, Manufacturing Base and Competitors
Table 24. Noven Major Business
Table 25. Noven Estrogen and Progestin Extended-Release Patches Product and Services
Table 26. Noven Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Noven Recent Developments/Updates
Table 28. AbbVie Basic Information, Manufacturing Base and Competitors
Table 29. AbbVie Major Business
Table 30. AbbVie Estrogen and Progestin Extended-Release Patches Product and Services
Table 31. AbbVie Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AbbVie Recent Developments/Updates
Table 33. Hisamitsu Pharmaceutical Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Hisamitsu Pharmaceutical Co., Inc. Major Business
Table 35. Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Product and Services
Table 36. Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
Table 38. Watson Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Watson Pharmaceuticals Major Business
Table 40. Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
Table 41. Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Watson Pharmaceuticals Recent Developments/Updates
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson Estrogen and Progestin Extended-Release Patches Product and Services
Table 46. Johnson & Johnson Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Johnson & Johnson Recent Developments/Updates
Table 48. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. ANI Pharmaceuticals Major Business
Table 50. ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product and Services
Table 51. ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. ANI Pharmaceuticals Recent Developments/Updates
Table 53. Zhejiang Yatai Pharmaceutical Company Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Zhejiang Yatai Pharmaceutical Company Ltd. Major Business
Table 55. Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Product and Services
Table 56. Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Zhejiang Yatai Pharmaceutical Company Ltd. Recent Developments/Updates
Table 58. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Estrogen and Progestin Extended-Release Patches Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Estrogen and Progestin Extended-Release Patches Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Estrogen and Progestin Extended-Release Patches, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Estrogen and Progestin Extended-Release Patches Production Site of Key Manufacturer
Table 63. Estrogen and Progestin Extended-Release Patches Market: Company Product Type Footprint
Table 64. Estrogen and Progestin Extended-Release Patches Market: Company Product Application Footprint
Table 65. Estrogen and Progestin Extended-Release Patches New Market Entrants and Barriers to Market Entry
Table 66. Estrogen and Progestin Extended-Release Patches Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Estrogen and Progestin Extended-Release Patches Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Estrogen and Progestin Extended-Release Patches Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Estrogen and Progestin Extended-Release Patches Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Estrogen and Progestin Extended-Release Patches Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 80. Global Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 81. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel (2018-2023) & (USD Million)
Table 82. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel (2024-2029) & (USD Million)
Table 83. Global Estrogen and Progestin Extended-Release Patches Average Price by Sales Channel (2018-2023) & (US$/Unit)
Table 84. Global Estrogen and Progestin Extended-Release Patches Average Price by Sales Channel (2024-2029) & (US$/Unit)
Table 85. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 88. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 89. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 96. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 97. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 104. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 105. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 112. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 113. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Estrogen and Progestin Extended-Release Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Estrogen and Progestin Extended-Release Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2018-2023) & (K Units)
Table 120. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Sales Channel (2024-2029) & (K Units)
Table 121. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Estrogen and Progestin Extended-Release Patches Raw Material
Table 126. Key Manufacturers of Estrogen and Progestin Extended-Release Patches Raw Materials
Table 127. Estrogen and Progestin Extended-Release Patches Typical Distributors
Table 128. Estrogen and Progestin Extended-Release Patches Typical Customers
LIST OF FIGURES
Figure 1. Estrogen and Progestin Extended-Release Patches Picture
Figure 2. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Type in 2022
Figure 4. Contraceptive Patch Examples
Figure 5. Estradiol Patch Examples
Figure 6. Others Examples
Figure 7. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Sales Channel in 2022
Figure 9. Online Sales Examples
Figure 10. Offline Sales Examples
Figure 11. Global Estrogen and Progestin Extended-Release Patches Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Estrogen and Progestin Extended-Release Patches Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Estrogen and Progestin Extended-Release Patches Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Estrogen and Progestin Extended-Release Patches Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Estrogen and Progestin Extended-Release Patches by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Estrogen and Progestin Extended-Release Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Estrogen and Progestin Extended-Release Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Estrogen and Progestin Extended-Release Patches Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 31. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Sales Channel (2018-2029)
Figure 32. Global Estrogen and Progestin Extended-Release Patches Average Price by Sales Channel (2018-2029) & (US$/Unit)
Figure 33. North America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 35. North America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 42. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 51. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Region (2018-2029)
Figure 53. China Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 61. South America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 67. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Estrogen and Progestin Extended-Release Patches Market Drivers
Figure 74. Estrogen and Progestin Extended-Release Patches Market Restraints
Figure 75. Estrogen and Progestin Extended-Release Patches Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Estrogen and Progestin Extended-Release Patches in 2022
Figure 78. Manufacturing Process Analysis of Estrogen and Progestin Extended-Release Patches
Figure 79. Estrogen and Progestin Extended-Release Patches Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Estrogen and Progestin Extended-Release Patches Picture
Figure 2. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Type in 2022
Figure 4. Contraceptive Patch Examples
Figure 5. Estradiol Patch Examples
Figure 6. Others Examples
Figure 7. Global Estrogen and Progestin Extended-Release Patches Consumption Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Sales Channel in 2022
Figure 9. Online Sales Examples
Figure 10. Offline Sales Examples
Figure 11. Global Estrogen and Progestin Extended-Release Patches Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Estrogen and Progestin Extended-Release Patches Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Estrogen and Progestin Extended-Release Patches Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Estrogen and Progestin Extended-Release Patches Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Estrogen and Progestin Extended-Release Patches by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Estrogen and Progestin Extended-Release Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Estrogen and Progestin Extended-Release Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Estrogen and Progestin Extended-Release Patches Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 31. Global Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Sales Channel (2018-2029)
Figure 32. Global Estrogen and Progestin Extended-Release Patches Average Price by Sales Channel (2018-2029) & (US$/Unit)
Figure 33. North America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 35. North America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 42. Europe Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 51. Asia-Pacific Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Region (2018-2029)
Figure 53. China Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 61. South America Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 67. Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Estrogen and Progestin Extended-Release Patches Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Estrogen and Progestin Extended-Release Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Estrogen and Progestin Extended-Release Patches Market Drivers
Figure 74. Estrogen and Progestin Extended-Release Patches Market Restraints
Figure 75. Estrogen and Progestin Extended-Release Patches Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Estrogen and Progestin Extended-Release Patches in 2022
Figure 78. Manufacturing Process Analysis of Estrogen and Progestin Extended-Release Patches
Figure 79. Estrogen and Progestin Extended-Release Patches Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
